Active04063329Private limited companyBrentwood

WALLACE PHARMA LIMITED

Significant control: Simon Robert Geoffrey Tate (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Wallace Pharma Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Wallace Pharma Limited sell?

Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

WALLACE PHARMA LIMITED is an active private limited company (company number 04063329) incorporated on 1 September 2000, registered in Brentwood. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest small accounts cover the period ending 31 December 2025, showing net assets of £291k, with 1 employee on average. Net assets were unchanged on the prior period.

Peer position · net assets

By net assets it sits in the top quarter of 661 comparable companies in the UK (median £265, upper quartile £89k).

02

Ownership and control

1 active · 1 other
  • Mr Simon Robert Geoffrey Tate
    Individual · since 6 April 2016
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Mrs Mary Joan Tate
    Individual · since 6 April 2016 · ceased 22 October 2024
    • owns 25–50% of shares
    • holds 25–50% of voting rights

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
1 September 200026 yrs ago
Next accounts due
30 September 2027in 341 days
Confirmation statement due
15 September 2027in 326 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 21100
Manufacture of basic pharmaceutical products
Accounts type
Total Exemption Full
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 31 December 2025
Net assets
£291k
No changevs Dec 2024
Cash at bank
Not reported
Turnover
Not reported
Employees
1
−50%vs Dec 2024
Net assets
£291k
Average employees
1
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2025£291k—£291k———1
31 December 2024£291k—£291k———2

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £290,576 at 31 December 2025
  • Incorporated five or more years agoIncorporated 1 September 2000

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Next accounts duein 341 days
  2. Confirmation statement duein 326 days
  3. Accounts period endNet assets £291k · small accounts
  4. Accounts period endNet assets £291k · small accounts
  5. Incorporated
08

Similar companies in Essex

Same activity (manufacture of basic pharmaceutical products), closest in incorporation date
09

Reminders for WALLACE PHARMA LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.